# ThIA Santé Mentale: Phase 1 study in Depression Chronic, Depression and Quality of Life (608 participants)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | ThIA Santé Mentale |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Remote Medical Monitoring of Patients With Depression |
| NCT ID | NCT07878754 |
| Phase | Phase 1 |
| Status | recruiting |
| Conditions | Depression Chronic; Depression and Quality of Life; Depression; Major Depressive Episode |
| Intervention types | device |
| Target enrollment | 608 |
| Site countries | France |
| Posted | 2026-10-16 |
| Planned start | 2026-04-01 |
| Event | Newly registered study |
| Event date | 2026-10-16 |

## Why this score
- Industry sponsor (buys outsourced services).
- 608 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07878754). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.